
NYSEHealthcareMedical - Diagnostics & Research
最新資料
US$219.87
+US$2.41 · +1.11%
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
前收盤價
US$219.87
+US$2.41 · +1.11%
盤中時間採用ET。市場資料可能有所延遲。
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
日內區間
目前US$219.87
52週區間
目前US$219.87
盤中時間採用ET。市場資料可能有所延遲。
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
日內區間
目前US$219.87
52週區間
目前US$219.87
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 245.68億 USD | 238.75億 USD | 238.9億 USD | 266.43億 USD | 294.53億 USD |
| 銷貨成本 | 95.98億 USD | 96.69億 USD | 98.56億 USD | 104.55億 USD | 115.01億 USD |
| 毛利 | 149.7億 USD | 142.06億 USD | 140.34億 USD | 161.88億 USD | 179.52億 USD |
| 研究與開發 | 15.98億 USD | 15.84億 USD | 15.03億 USD | 15.28億 USD | 17.42億 USD |
| 銷售、一般及管理費用 | 82.35億 USD | 74.38億 USD | 72.52億 USD | 71.24億 USD | 81.6億 USD |
| 營業費用 | 98.33億 USD | 90.22億 USD | 87.55億 USD | 86.52億 USD | 99.02億 USD |
| 利息收入 | 3000萬 USD | 1.17億 USD | 3.03億 USD | 4100萬 USD | 1100萬 USD |
| 利息支出 | 2.65億 USD | 2.78億 USD | 2.89億 USD | 2.07億 USD | 2.41億 USD |
| 折舊和攤銷 | 24.47億 USD | 23.52億 USD | 21.66億 USD | 21.32億 USD | 21.68億 USD |
| 營業利益 | 51.37億 USD | 51.84億 USD | 52.79億 USD | 75.36億 USD | 80.5億 USD |
| 淨利 | 36.14億 USD | 38.99億 USD | 47.64億 USD | 72.09億 USD | 64.33億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
年度分割調整後的每股現金分配。
US$1.28
2025年(完整年度)+71.9% 自從 2021
2026年(部分年度):US$1.20
US$0.7447
2,021
US$0.8865
2,022
US$0.9887
2,023
US$1.08
2,024
US$1.28
2,025
US$1.20
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年9月30日 | US$0.40Quarterly | 2026年9月30日 | 2026年10月30日 |
股息 | 2026年6月26日 | US$0.40Quarterly | 2026年6月26日 | 2026年7月31日 |
股息 | 2026年3月27日 | US$0.40Quarterly | 2026年3月27日 | 2026年4月24日 |
股息 | 2025年12月26日 | US$0.32Quarterly | 2025年12月26日 | 2026年1月30日 |
股息 | 2025年9月26日 | US$0.32Quarterly | 2025年9月26日 | 2025年10月31日 |
股息 | 2025年6月27日 | US$0.32Quarterly | 2025年6月27日 | 2025年7月25日 |
除息 2026年9月30日
US$0.40
Quarterly
2026年9月30日登記 · 支付日 2026年10月30日
除息 2026年6月26日
US$0.40
Quarterly
2026年6月26日登記 · 支付日 2026年7月31日
除息 2026年3月27日
US$0.40
Quarterly
2026年3月27日登記 · 支付日 2026年4月24日
除息 2025年12月26日
US$0.32
Quarterly
2025年12月26日登記 · 支付日 2026年1月30日
除息 2025年9月26日
US$0.32
Quarterly
2025年9月26日登記 · 支付日 2025年10月31日
除息 2025年6月27日
US$0.32
Quarterly
2025年6月27日登記 · 支付日 2025年7月25日
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T2629.5億0.20%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI43.24億0.18%2.3兆 USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO35.74億0.20%1.8兆 USD0.03%US$715.59+0.61%
iShares Core S&P 500 ETFIVV18.09億0.20%8964.4億 USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY16.61億0.20%8172億 USD0.09%US$778.57+0.60%
Vanguard Morningstar Value ETFVTV13億0.50%2624億 USD0.03%US$220.59+0.44%
State Street Health Care Select Sector SPDR ETFXLV9.69億2.23%435.37億 USD0.08%US$170.81+1.58%
Vanguard Dividend Appreciation ETFVIG7.62億0.57%1324億 USD0.04%US$239.05+0.70%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。